News

Researchers use computational modeling to understand why some flu viruses cause more severe infections.

Researchers have developed a new method for differentiating between T and B cells, in the form of a probe with high specificity for B cells.

Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.

New measles and Nipah research offers a window into viral assembly, revealing how future therapies might stop these viruses in their tracks.

Researchers have used a novel strategy to study host cell proteins that contribute to the multiplication of the Lassa virus, which causes a severe hemorrhagic fever disease. This could lead to potential new drug targets for treating the disease.

Researchers found that antibiotics have sex-specific effects on the gut microbiome makeup of male and female laboratory rats, which could have implications for use in humans.

A new research study of over 5,000 pregnant women has found that infection with SARS-CoV-2 is associated with increased risk of preterm birth. However, this increased risk only exists if women are infected in their third trimester.

Researchers have demonstrated how machine learning models can reveal interactions between a patient's gut microbiome and their response to immunotherapy, in findings that may ultimately improve cancer patient outcomes.

Testing vaccines in the field is challenging and requires large number of volunteers and long periods of follow-up. Now, scientists report a new way to test vaccines that may be as rigorous and stringent as exposure to field strains of malaria.

Scientists are investigating how cyanobacteria sense and respond to CO2. Their research could lead to new strategies for carbon capture.